Merck Launches Lung Cancer Targeted Therapy Tepmetko® (Tepotinib) in China

On February 2, Merck announced the commercial launch of its lung cancer targeted drug Tepotinib (Tepmetko®) in China, officially supplying it to hospitals and pharmacies nationwide. (Jiemian)Original link